Vertex taps a team player to take over as CMO during a big transition at the top
Incoming Vertex CEO Reshma Kewalramani has selected her replacement as CMO, choosing to promote a member of the R&D team to the post. Carmen Bozic, who joined the company last May from Biogen, has been named EVP, Global Medicines Development and Medical Affairs today and gets to add the new title of CMO next April as Vertex cautiously transfers the reins to a new CEO who will have lots to do winning over some skeptical analysts.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.